Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111148202 | 11114820 | 2 | F | 20160720 | 20150515 | 20160720 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-029333 | BRISTOL MYERS SQUIBB | 0.00 | Y | 0.00000 | 20160720 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111148202 | 11114820 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Unknown | U | 20972 | ||||||||||
111148202 | 11114820 | 2 | I | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Unknown | U | 0 | TABLET | |||||||||
111148202 | 11114820 | 3 | SS | FAMOTIDINE. | FAMOTIDINE | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 4 | SS | RANITIDINE. | RANITIDINE | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 5 | SS | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 6 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 7 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 8 | I | RITONAVIR. | RITONAVIR | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 9 | SS | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 10 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Unknown | U | 0 | ||||||||||
111148202 | 11114820 | 11 | SS | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
111148202 | 11114820 | 1 | Antiretroviral therapy |
111148202 | 11114820 | 2 | Antiretroviral therapy |
111148202 | 11114820 | 3 | Product used for unknown indication |
111148202 | 11114820 | 4 | Product used for unknown indication |
111148202 | 11114820 | 5 | Product used for unknown indication |
111148202 | 11114820 | 6 | Product used for unknown indication |
111148202 | 11114820 | 7 | Product used for unknown indication |
111148202 | 11114820 | 8 | Antiretroviral therapy |
111148202 | 11114820 | 9 | Product used for unknown indication |
111148202 | 11114820 | 10 | Product used for unknown indication |
111148202 | 11114820 | 11 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
111148202 | 11114820 | Drug interaction | |
111148202 | 11114820 | Medication error |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |